TLR5: A prognostic and monitoring indicator for triple-negative breast cancerDai Shi(Shandong University), Guihua Hou(Shandong University)Cell Death and DiseaseDecember 18, 201910.1038/s41419-019-2187-8Cited by 39SaveCiteExport RISWatch citationsRelated PapersEvaluation of 131I-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma|PLoS ONE|2014|7